MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 39 filers reported holding MEDICINES CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $35,146,000 | +20.5% | 29,070,000 | 0.0% | 0.46% | +15.3% |
| Q1 2019 | $29,169,000 | +183.6% | 29,070,000 | +144.1% | 0.40% | +221.0% |
| Q4 2018 | $10,285,000 | -87.5% | 11,910,000 | -84.4% | 0.12% | -87.0% |
| Q3 2018 | $82,074,000 | +30.8% | 76,410,000 | +47.9% | 0.95% | +17.5% |
| Q2 2018 | $62,769,000 | +16.7% | 51,660,000 | +10.7% | 0.81% | +16.7% |
| Q1 2018 | $53,798,000 | +27.9% | 46,660,000 | +17.7% | 0.70% | +63.4% |
| Q4 2017 | $42,069,000 | +212.4% | 39,660,000 | +272.1% | 0.43% | +185.9% |
| Q3 2017 | $13,467,000 | -78.2% | 10,657,000 | -77.5% | 0.15% | -81.0% |
| Q2 2017 | $61,720,000 | -46.1% | 47,410,000 | -34.5% | 0.78% | -55.9% |
| Q1 2017 | $114,404,000 | +23.6% | 72,400,000 | -5.9% | 1.78% | +48.5% |
| Q4 2016 | $92,561,000 | +12.0% | 76,900,000 | +20.3% | 1.20% | -3.2% |
| Q3 2016 | $82,663,000 | +563.3% | 63,900,000 | +508.6% | 1.24% | +553.4% |
| Q2 2016 | $12,462,000 | – | 10,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 4,201,000 | $4,842,000 | 4.21% |
| Cheyne Capital Management (UK) LLP | 5,000,000 | $5,773,000 | 2.61% |
| SILVERBACK ASSET MANAGEMENT LLC | 11,000,000 | $12,690,000 | 2.49% |
| DLD Asset Management, LP | 22,500,000 | $26,072,000 | 2.35% |
| Myriad Asset Management Ltd. | 15,000,000 | $17,301,000 | 1.55% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,551,000 | $6,387,000 | 1.18% |
| TFG Asset Management GP Ltd | 5,000,000 | $5,830,000 | 0.90% |
| WOLVERINE ASSET MANAGEMENT LLC | 46,660,000 | $53,798,000 | 0.70% |
| CSS LLC/IL | 10,983,000 | $12,651,000 | 0.63% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $6,920,000 | 0.51% |